NCT03641417View on ClinicalTrials.gov

Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT)

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

March 13, 2020

Conditions
ObesityBariatric Surgery CandidateAppetitive Behavior
Interventions
DRUG

GLWL-01

"Small molecule inhibitor of Ghrelin-O-Acyltransferase (GOAT) to reduce levels of circulating acyl ghrelin.~(Defined as a mechanistic study by MHRA; intervention not for therapeutic purposes in this study.)"

OTHER

Placebo

Same as GLWL-01, but no active ingredient

Trial Locations (1)

Unknown

University College London, London

All Listed Sponsors
lead

University College, London

OTHER

NCT03641417 - Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT) | Biotech Hunter | Biotech Hunter